Skip to main content

Advertisement

Table 1 Summary demographics of the AD/control cohort

From: CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

  n Gender (M:F) Age (mean years ± SD) Aβ42 (mean ng/L ± SEM) p-tau (mean ng/L ± SEM) t-tau (mean ng/L ± SEM)
Control 39 23:16 68.2 ± 11.9 834.18 ± 32.67 40.28 ± 1.58 234.67 ± 11.42
AD 39 25:14 76.2 ± 6.11 435.18 ± 11.88 84.79 ± 3.21 725.69 ± 36.31